These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1913702)

  • 1. Effect of clonidine and atropine on rest tremor in the MPTP monkey model of parkinsonism.
    Gomez-Mancilla B; Boucher R; Bédard PJ
    Clin Neuropharmacol; 1991 Aug; 14(4):359-66. PubMed ID: 1913702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
    Gomez-Mancilla B; Boucher R; Bédard PJ
    Mov Disord; 1992; 7(1):43-7. PubMed ID: 1348351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ethosuximide on rest tremor in the MPTP monkey model.
    Gomez-Mancilla B; Latulippe JF; Boucher R; Bédard PJ
    Mov Disord; 1992; 7(2):137-41. PubMed ID: 1350061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tremor in MPTP-induced parkinsonism.
    Tetrud JW; Langston JW
    Neurology; 1992 Feb; 42(2):407-10. PubMed ID: 1736174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys.
    Kuno S; Mizuta E; Nishida J; Takechi M
    Clin Neuropharmacol; 1992 Oct; 15(5):381-6. PubMed ID: 1384970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an alpha 2 antagonist in a 20-year-old Java monkey with MPTP-induced parkinsonian signs.
    Colpaert FC; Degryse AD; Van Craenendonck HV
    Brain Res Bull; 1991 Apr; 26(4):627-31. PubMed ID: 1678307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old Java monkey [Macaca cynomolgus fascicularis (Raffles)].
    Degryse AD; Colpaert FC
    Brain Res Bull; 1986 May; 16(5):561-71. PubMed ID: 3488798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of SKF 38393-A to relieve parkinsonian symptoms induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.
    Close SP; Marriott AS; Pay S
    Br J Pharmacol; 1985 Jun; 85(2):320-2. PubMed ID: 3928007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism.
    Schultz W; Studer A; Jonsson G; Sundström E; Mefford I
    Neurosci Lett; 1985 Aug; 59(2):225-32. PubMed ID: 3877257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rest tremor in rhesus monkeys with MPTP-induced parkinsonism.
    Emborg ME; Tetrud JW; Moirano J; McLaughlin WW; Bankiewicz KS
    Front Biosci; 2003 May; 8():a148-54. PubMed ID: 12700090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism.
    Graham WC; Robertson RG; Sambrook MA; Crossman AR
    Life Sci; 1990; 47(18):PL91-7. PubMed ID: 2250573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new device for the quantitative assessment of dopaminergic drug effects in unilateral MPTP-lesioned monkeys.
    Wolters EC; Kebabian JC; Guttman M; Mak E; Pate BD; Calne DB
    Neurosci Lett; 1988 Dec; 95(1-3):257-61. PubMed ID: 3265771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey.
    Bezard E; Imbert C; Deloire X; Bioulac B; Gross CE
    Brain Res; 1997 Aug; 766(1-2):107-12. PubMed ID: 9359593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake.
    Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
    Neurosci Lett; 1986 Jan; 63(1):61-5. PubMed ID: 3485267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effects of cabergoline and L-dopa on parkinsonism in MPTP-treated cynomolgus monkeys.
    Arai N; Isaji M; Kojima M; Mizuta E; Kuno S
    J Neural Transm (Vienna); 1996; 103(11):1307-16. PubMed ID: 9013417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural effects of (+)-4-propyl-9-hydroxynaphthoxazine in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Clarke CE; Boyce S; Sambrook MA; Stahl SM; Crossman AR
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):35-8. PubMed ID: 2907097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The catecholamine uptake blocker nomifensine protects against MPTP-induced parkinsonism in monkeys.
    Schultz W; Scarnati E; Sundström E; Tsutsumi T; Jonsson G
    Exp Brain Res; 1986; 63(1):216-20. PubMed ID: 3488228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
    Doudet D; Gross C; Lebrun-Grandié P; Bioulac B
    C R Seances Soc Biol Fil; 1985; 179(1):85-97. PubMed ID: 3161601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The partial dopamine receptor agonist terguride in the MPTP-induced hemiparkinsonian monkey model.
    Brücke T; Bankiewicz K; Harvey-White J; Kopin I
    Eur J Pharmacol; 1988 Apr; 148(3):445-8. PubMed ID: 3260191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Yoshimura N; Mizuta E; Kuno S; Sasa M; Yoshida O
    Neuropharmacology; 1993 Apr; 32(4):315-21. PubMed ID: 8098860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.